Cimetidine and Coumarin Therapy of Renal Cell Carcinoma. A Pilot Study
Authors
Affiliations
Thirty-eight patients with metastatic renal-cell carcinoma (RCC) and 1 patient with a second primary RCC were treated with coumarin and cimetidine. Patients received 400 mg cimetidine p.o. daily and after 1 week 100 mg coumarin p.o. daily in addition until tumour progression. Two complete remission (30 and 50+ months) and 3 partial remissions (14, 13.8 months) could be achieved. Problems regarding possibly spontaneous regressions and comparable results of other treatment in RCC are discussed.
Khan A, Ikram M, Rehman S, Khan R, Puduvalli V, Jadoon A Heliyon. 2023; 9(7):e17601.
PMID: 37456028 PMC: 10338367. DOI: 10.1016/j.heliyon.2023.e17601.
Challenges in the Heterologous Production of Furanocoumarins in .
Rodrigues J, Gomes D, Rodrigues L Molecules. 2022; 27(21).
PMID: 36364054 PMC: 9656933. DOI: 10.3390/molecules27217230.
Bajalia E, Azzouz F, Chism D, Giansiracusa D, Wong C, Plaskett K Cancers (Basel). 2022; 14(13).
PMID: 35805049 PMC: 9265746. DOI: 10.3390/cancers14133278.
Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms.
Sharifi-Rad J, Cruz-Martins N, Lopez-Jornet P, Pons-Fuster Lopez E, Harun N, Yeskaliyeva B Oxid Med Cell Longev. 2021; 2021:6492346.
PMID: 34531939 PMC: 8440074. DOI: 10.1155/2021/6492346.
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer.
Akkol E, Genc Y, Karpuz B, Sobarzo-Sanchez E, Capasso R Cancers (Basel). 2020; 12(7).
PMID: 32707666 PMC: 7409047. DOI: 10.3390/cancers12071959.